| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 16 |
| 1 | PREDNISONE | 14 |
| 2 | ADALIMUMAB | 13 |
| 3 | OMEPRAZOLE | 12 |
| 4 | LEVOTHYROXINE SODIUM | 11 |
| 5 | LISINOPRIL | 10 |
| 6 | ERGOCALCIFEROL | 9 |
| 7 | IBUPROFEN | 9 |
| 8 | METHYLPREDNISOLONE | 9 |
| 9 | DENOSUMAB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-ADBM | 1 | 0.0037 |
| 1 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 2 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 3 | ECALLANTIDE | 2 | 0.0011 |
| 4 | ATROPINE SULFATE INJECTION | 2 | 0.0008 |
| 5 | ATROPINE SULFATE MONOHYDRATE | 2 | 0.0008 |
| 6 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 2 | 0.0007 |
| 7 | ESTROGEN | 2 | 0.0007 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 9 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 32 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Benzodiazepine [EPC] | 17 |
| 3 | Proton Pump Inhibitor [EPC] | 14 |
| 4 | Kinase Inhibitor [EPC] | 12 |
| 5 | GLP-1 Receptor Agonist [EPC] | 10 |
| 6 | Osmotic Laxative [EPC] | 9 |
| 7 | Provitamin D2 Compound [EPC] | 9 |
| 8 | Vitamin C [EPC] | 9 |
| 9 | RANK Ligand Inhibitor [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | Provitamin D2 Compound [EPC] | 9 | 0.0003 |
| 7 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 8 | Human C1 Esterase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Human alpha-1 Proteinase Inhibitor [EPC] | 1 | 0.0002 |